Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±¹¼ÒÁøÇà µÎ°æºÎ¾Ï¿¡¼­ ¹æ»ç¼± ´Üµ¶Ä¡·á¿Í Ç×¾ÏÁ¦ º´¿ëÄ¡·áÀÇ ºñ±³ Comparison of Radiation Therapy and Combined Chemotherapy and Radiation Therapy for Locally Advanced Head and Neck Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 4È£ p.616 ~ 622
¼Ò¼Ó »ó¼¼Á¤º¸
À̱ÔÅà º¯ÀçÈ£/Ȳº¸±Ç/¸ñÁö¿À/±èÀº¼®/¿øÁ¾È£/¹é½ÂÈ£/ÃÖµÎÈ£/È«´ë½Ä

Abstract

¼­·Ð
µÎ°æºÎ¾ÏÀº ¹ß°ß´ç½Ã ÁøÇິ±â°¡ ´ëºÎºÐÀ» Â÷ÁöÇÏ°í ÀÖ°í, ÀÌ·± °æ¿ì Ä¡·á¿¡ ¹ÝÀÀÀÌ ³·Àº
°ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ±¹¼ÒÀüÀÌ·Î ÀÎÇÏ¿© ¼ö¼úÀÌ ºÒ°¡´ÉÇÑ ±¹¼ÒÁøÇà µÎ°æºÎ¾ÏÀÇ Ä¡·á´Â Å©°Ô
¹æ»ç¼±¿ä¹ý°ú Ç×¾ÏÁ¦¿¡ ÀÇÇÑ È­Çпä¹ýÀ¸·Î ´ëº°ÇÒ ¼ö Àִµ¥, ±× Áß¿¡¼­ ±ÙÄ¡Àû ¹æ»ç¼±¿ä¹ý
ÀÌ Ç¥ÁØ¿ä¹ýÀ̳ª ÀÌ´Â ±¹¼ÒÄ¡·áÈ¿°ú´Â ¿ì¼öÇϳª ±¹¼ÒÀç¹ß ¹× ¿ø°ÝÀüÀÌ°¡ ÈçÇÏ¿© ÀüÅëÀûÀÎ
¹æ»ç¼±¿ä¹ýÀ¸·Î ´Üµ¶Ä¡·á ½Ã 2³â »ç¸Á·üÀÌ 70% ÀÌ»óÀ¸·Î Àå±â »ýÁ¸·üÀº ¸Å¿ì ³·Àº °ÍÀ¸·Î
µÇ¾î ÀÖ´Ù.
Ç×¾ÏÁ¦ º´¿ëÄ¡·á¿¡ ´ëÇÑ ¿¬±¸´Â 1960³â´ë ÀÌÈÄ È°¹ßÈ÷ ÀÌ·ç¾î Á³À¸¸ç, ¿ì¸® ³ª¶ó¿¡¼­µµ
1985³â ±èµîÀÌ µÎ°æºÎ »óÇǼ¼Æ÷¾Ï¿¡ ´ëÇÑ À¯µµÈ­Çпä¹ýÀÇ È¿°ú¿¡ ´ëÇÏ¿© º¸°íÇÑ ÀÌ·¡ ¼ö¼ú
ÀÌ ºÒ°¡´ÉÇÑ µÎ°æºÎ Á¾¾ç¿¡ ´ëÇÑ À¯µµÈ­Çпä¹ý¿¡ ´ëÇÏ¿© ¸¹Àº ¿¬±¸°¡ ÀÌ·ç¾î Á³´Ù. ÀÌ·± Ç×
¾ÏÈ­Çпä¹ý¿¡ ¹æ»ç¼± º´ÇàÄ¡·á¸¦ Ãß°¡ÇÏ°Ô µÇ¸é ±¹¼ÒÀûÀÎ Á¶ÀýÀ» Áõ°¡½ÃÅ°°í ¿ø°ÝÀüÀ̸¦ ¾ï
Á¦ÇÏ´Â ÀåÁ¡ÀÌ ÀÖ´Ù. Ç×¾ÏÈ­Çпä¹ý Á¦Àç·Î´Â °í¿ë·®ÀÇ cisplatinÀ» Æ÷ÇÔÇÑ 5-FU, Bleomycin,
Methotrexate, LeucovorinµîÀÇ Ç×¾ÏÈ­Çпä¹ýÀÌ Áö±Ý±îÁö À¯¿ëÇÑ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç ƯÈ÷
cisplatinÀº ¹æ»ç¼±Ä¡·á¿¡ »ó½ÂÈ¿°ú¸¦ ³ªÅ¸³»´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
º» ¿¬±¸´Â À¯µµÇ×¾ÏÈ­Çпä¹ý°ú ¹æ»ç¼±Ä¡·á¸¦ º´¿ëÇÏ´Â º´¿ë¿ä¹ýÀÌ °üÇØÀ²°ú »ýÁ¸À²À» ³ô
ÀÏ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ´Â °¡¿îµ¥ ±¹¼ÒÁøÇà µÎ°æºÎ¾Ï¿¡¼­ cisplatin°ú 5-FU¸¦ ÀÌ¿ë
ÇÑ Ç×¾ÏÈ­Çпä¹ýÀ» ÀÌ¿ëÇÏ¿©, À¯µµÇ×¾ÏÈ­Çпä¹ý ÈÄ ¹æ»ç¼±Ä¡·á¸¦ º´ÇàÇÑ ±º°ú ¹æ»ç¼± ´Üµ¶
Ä¡·á ±ºÀÇ Ä¡·á È¿°ú¸¦ ÈÄÇâÀûÀ¸·Î ºñ±³ ºÐ¼®ÇÏ¿´´Ù.
#ÃÊ·Ï#
Purpose: In locally advanced head and neck cancer, radiation therapy is currently
unsatisfactory because the end result is often limited regional disease control and
survival. A clinical study was carried out to compare the effectiveness between the
radiation therapy and the combined chemotherapy and radiation therapy.
Materials and Method: Thirty-six patients with previously untreated, locally advanced
squamous cell carcinoma of the head and neck were treated with radiotherapy alone and
combined chemo-radiotherapy. Induction chemotherapy was administered 2¡­3 cycles,
consisting of intravenous cisplatin(100 mg/m2 on day 1) and
5-fluorouracil(1000 mg/m2/day for 5 days as a continuous infusion) every
4 weeks followed by 7¡­8 weeks of radiation therapy for a total dose of 60¡­75 Gy.
Results: 1) Among 36 locally advanced head and neck cancer, 17 patients received
radiation therapy alone and 19 patients received combined chromo-radiotherapy,
respectively. 2) Response rate was 47%(complete response 29%, and partial response
18%) in radiation therapy group and 79%(complete response 37%, and partial response
42%) in combined chemo-radiotherapy group(p<0.05). 3) In median survival, radiation
therapy group was 13 months and combined chemo-radiotherapy group was 15 months.
Both groups were not significantly different(p>0.05). 4) Treatment related mortality was
not noted, but the toxic effects were seen on the half cases of the both groups. Grade II
toxicities were similar between the two arms.
Conclusion: Combined chemotherapy and radiation therapy was more effective in local
control but not superior in survival than radiation therapy alone. Continuous evaluation
and identification of proper sequence for the therapeutic modality is supposed to prolong
the survival of patients.

Å°¿öµå

Head and neck cancer; Cisplatin; Fluorouracil; Radiotherapy;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS